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SUMMARY – In the study, we evaluated 61 multiple sclerosis patients hospitalized at our 
hospital in the period from October 1, 2013 to february 15, 2014. The aim of the study was to 
investigate pain syndromes associated with the underlying disease. Pain in the month preceding 
assessment was reported by 90% of patients. Most patients suffered from low back pain (52%) and 
musculoskeletal pain (39%), followed by neck pain (31%), painful tonic spasm (26%), neuropathic 
extremity pain (23%) and pain due to spasticity (21%). Other types of pain were present in less than 
20% of patients. A total of 67% of patients were taking analgesics; the most frequently used were 
nonsteroidal antiinflammatory drugs, while drugs against neuropathic pain were taken by a smaller 
number of patients. The high incidence of pain syndromes pointed to the importance of regular 
physical therapy procedures.
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Introduction 
Pain is an unpleasant sensory and emotional ex-
perience associated with existing or impending tissue 
damage (International Association for the Study of 
Pain, 2012 revised definition). based on the patho-
genesis, pain can be nociceptive, neuropathic or psy-
chosomatic. Nociceptive pain occurs due to existing 
or impending damage to non-neural tissue and results 
from the activation of nociceptors – sensory pain re-
ceptors in the peripheral somatosensory nervous sys-
tem. It is classified as somatic or visceral pain. Somatic 
pain occurs through the activation of nociceptors lo-
cated in somatic structures (skin, subcutaneous tissue, 
muscles and joints). Visceral pain is initiated through 
the activation of nociceptors located in visceral struc-
tures (internal organs). 
Neuropathic pain is caused by damage to or disease 
of the somatosensory nervous system. It is classified as 
either central or peripheral. Central neuropathic pain 
is caused by damage to or disease of the central so-
matosensory nervous system (spinal cord, brainstem, 
thalamus and its projections towards the cerebral cor-
tex). Peripheral neuropathic pain is caused by damage 
to or disease of the peripheral somatosensory nervous 
system. It occurs in conditions that affect individual 
or multiple nerves (neuralgia of the nerves, polyneu-
ropathy, radiculopathy).
Previous studies have often ignored pain as an 
important symptom in patients with multiple scle-
rosis (MS)1. The estimated prevalence of pain in pa-
tients with MS varies in different studies from 26% 
to 86%2-11. The reason behind this is the existence of 
large differences in the patient sample surveyed, use 
of different research methods, testing different pain 
localizations and use of different criteria for defining a 
particular pain syndrome associated with MS9. There 
is no internationally recognized classification of pain 
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syndromes in MS patients. 
This study involved the use of a modified classifi-
cation as proposed by Truini et al.12. The mentioned 
authors classify pain in those suffering from MS as 
neuropathic pain (neuropathic pain in the limbs, 
trigeminal neuralgia, Lhermitte’s sign), mixed pain 
(painful tonic spasms, pain due to spasticity), nocice-
ptive pain (pain due to optic neuritis, musculoskeletal 
and joint pain, back pain, migraine, tension headache, 
pain due to therapy) and other pain syndromes.
Patients and Methods
This study analyzed the presence, incidence, local-
ization, type and strongest intensity of pain in patients 
with MS over a period of one month prior to hospital-
ization in our institution. In addition, the frequency 
and types of analgesics used in the mentioned period 
were analyzed.
Respondents were people with MS who underwent 
inpatient rehabilitation in the Lipik Special hospital 
for Medical Rehabilitation in the period between Oc-
tober 1, 2013 and february 15, 2014.
The study included patients older than 18 years 
with a diagnosis of MS according to the revised Mc-
Donald criteria13.
The exclusion criterion was serious cognitive dam-
age. based on the exclusion criterion, three patients 
were not enrolled in the study. Information was col-
lected on each patient regarding their age, gender, 
type of MS, time elapsed since being diagnosed, pres-
ence of pain, pain severity, analgesic and spasmolytic 
therapy.
In each patient, the level of incapacity was deter-
mined based on the Expanded Disability Status Scale 
(EDSS) score14.
The severity of pain was measured using a visual 
analog scale (VAS), whereas cognitive status assess-
ment was performed using the Mini Mental Status15.
The study was approved by the hospital Ethics 
Committee, and a written consent for participation 
was obtained from study patients.
Results 
The study included 61 subjects, 44 (72%) women 
and 17 (28%) men, mean age 47.5 (range, 27-71). The 
mean time elapsed since being diagnosed with MS 
was 10.9 years (range, 6 months to 38 years). Of the 
total number of patients, 35 (57%) patients had the 
relapsing-remitting form of the disease (RRMS), 22 
(36%) secondary progressive form (SPMS), and four 
(7%) primary progressive form (PPMS) (fig. 1). 
The mean EDSS was 5.5 (range, 1.5-9). fifty-five 
(90%) patients reported experiencing pain for one 
month prior to hospitalization, 44 (72%) of them hav-
ing experienced pain in more than one location. Most 
patients had back pain, followed by musculoskeletal 
and joint pain, neck pain, painful tonic spasms, neu-
ropathic pain and pain in the extremities caused by 
spasticity. Less than 20% experienced the following 
in the respective order: migraine headaches, group 
of other types of pain, tension headaches and Lher-
mitte’s phenomenon, pain due to therapy, and neural-
gia of the trigeminal nerve. 
Fig. 1. Types of multiple sclerosis.
RRMS = relapsing-remitting MS; SPMS = secondary progressive 
MS; PPMS = primary progressive MS
Table 1. Incidence of particular pain syndromes
Pain syndrome  n  %
Neuropathic extremity pain  14  23
Trigeminal neuralgia  2  3
Lhermitte's sign  5  8
Painful tonic spasm  16  26
Spasticity pain  13  21
Optic neuritis pain  0  0
Muscle, joint and skeletal pain  24  39
Low back pain  32  52
Migraine  10  16
Tension-type headache  5  8
Treatment-induced pain  4  7
Other pain  7  11
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None of the patients had optic neuritis during that 
period. There were two patients in the group experi-
encing other types of pain who complained of pain in 
the abdomen, followed by two who had pain in their 
eyes and one patient with post-herpetic neuralgia, 
pain in the chest and due to decubitus ulcer. Pain as 
a side effect of therapy was reported by four subjects; 
two had myalgia as a result of taking interferon, and 
another two pain due to needle injections when taking 
glatiramer acetate (Table 1). 
Analysis of average pain intensity of each pain 
syndrome measured according to VAS revealed that 
patients reported tonic spasms as the most painful 
syndrome, followed by migraine headaches, then back 
pain and neuropathic pain in the extremities (fig. 2). 
forty-one (67%) patients were taking analgesics, 18% 
of them on daily basis (fig. 3). 
Analysis of the types of analgesics showed that 
58% of patients were taking nonsteroidal antirheu-
Fig. 2. Mean pain intensity according to localization (visual analog scale).
Table 2. Drug used for neuropathic pain relief
Drug  n  %
Antiepileptic  3  23
Antidepressant  0  0
Tramadol  8  62
Combination  2  15
matic drug as monotherapy, 15% a drug to reduce 
neuropathic pain as monotherapy, 10% other analge-
sics (paracetamol alone or in combination with anal-
gesics), and a combination of non-steroidal antirheu-
matic drugs and medication to reduce neuropathic 
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Among drugs taken for neuropathic pain relief, 
tramadol was most common, followed by antiepilep-
tic, and then a combination of tramadol and antiepi-
leptic drugs (Table 2). Spasmolytics were taken by 27 
(45%) patients, of which 15 (56%) took baclofen, 9 
(33%) diazepam, and three (11%) took a combination 
of these two drugs.
Discussion
The study showed the presence of pain in 90% of 
patients with MS. Due to differences in patient sam-
ple, use of different research methods, testing of dif-
ferent localizations of pain and use of different criteria 
to define a particular pain syndrome associated with 
MS, only a partial comparison with other studies is 
possible.
Studies that conducted meta-analyses have shown 
the incidence of pain in 75% of patients over a period 
of one month prior to testing9. In a meta-analysis con-
ducted by foley et al., the studies included different 
periods when testing pain and the incidence of pain 
was 63%7.
In a study by Archibald et al., which included 85 
patients, the incidence of pain for a period of one 
month prior to testing was 53%16, while the study by 
bacher Svendsen et al., which included 771 patients, 
showed that pain was more frequent in 79.4% of the 
respondents2. Our study showed a slightly higher in-
cidence of pain syndromes compared to these stud-
ies. This may be because our patients were referred to 
inpatient rehabilitation, thereby excluding those with 
minor functional deficits that are rarely treated as in-
patients.
Most of our patients had back pain (52%), mus-
culoskeletal and joint pain (39%), neck pain (31%), 
painful tonic spasms (26%), neuropathic pain in the 
extremities (23%), pain due to spasticity (21%) and 
migraine headaches (16%).
Compared to a meta-analysis that included 17 
studies7, comparable incidence of neuropathic pain 
in the extremities and trigeminal neuralgia was re-
corded in our study; however, we found less head-
aches (migraines and tension headaches), while there 
was a higher incidence of back pain and painful tonic 
spasms.
The highest incidence of back pain including mus-
culoskeletal and joint pain could be explained by the 
fact that these pains are common in the general popu-
lation17-19, while Truini et al. conclude that postural 
abnormalities caused by neurologic deficits contribute 
to an increase in the prevalence of the listed pain syn-
dromes12.
Analyzing the intensity of pain in a particular pain 
syndrome, it becomes evident that the most painful 
experience are tonic spasms, followed by migraine 
headaches, then back pain and neuropathic pain in 
the extremities.
A total of 67% of respondents were taking analge-
sics, 90% of them experiencing pain. Another 11% of 
patients experiencing pain were taking only spasmo-
lytics (as monotherapy). This means that some patients 
were avoiding taking analgesics (stating concern about 
the drug side effects), while some were mitigating the 
effects of pain by using spasmolytics as monotherapy.
Nonsteroidal antirheumatic drugs were the most 
often administered analgesics. Drugs for reducing neu-
ropathic pain, predominantly tramadol, were taken by 
a small number of patients, followed by antiepileptic 
drugs. None of the study patients was taking antide-
pressants, which are otherwise also recommended for 
the treatment of pain20. fourteen patients were taking 
medication for reducing neuropathic pain, alone or in 
combination with nonsteroidal antirheumatic drugs. 
In the total sample, 20 patients had pain classified as 
neuropathic in the narrow sense (neuropathic pain in 
the extremities, Lhermitte’s sign, trigeminal neural-
gia). Of these 20 patients, seven were taking medi-
cation for reducing neuropathic pain, while another 
seven were taking tramadol for back pain, neck and 
muscle-joint-bone pain. When taking into account 
that chronic back pain was also partly experienced as a 
neuropathic component, hypo-utilization of the listed 
drug groups is also a possibility, but only a small num-
ber of patients may have had an impact on the result.
Conclusions 
Pain is a common problem in people with MS. In 
this study, pain was present in 90% of patients over 
a period of one month prior to hospitalization. The 
most common form of pain was back pain including 
musculoskeletal and joint pain, partly due to the high 
prevalence of pain syndromes listed in the general 
population. Postural abnormalities caused by neu-
rologic deficits are an additional cause of these pain 
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syndromes.
Approximately 20%-25% of respondents stated 
that they were affected by neuropathic pain in the 
extremities, painful tonic spasms and pain caused by 
spasticity. The above syndromes in the sample of pa-
tients may be associated with MS.
A total of 67% of the respondents were taking anal-
gesics and 25% were taking drugs four days a week or 
more frequently. The most common were nonsteroidal 
antirheumatic drugs, while drugs for reducing neu-
ropathic pain were taken only by a small number of 
patients.
Given the prevalence of pain syndromes and fre-
quent use of analgesics, it becomes evident that regu-
lar physical therapy procedures are important; besides 
being aimed at reducing functional deficit or main-
taining an existing one, they significantly influence 
reduction of pain components.
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Sažetak
bOLNI SINDROMI U ObOLJELIh OD MULTIPLE SkLEROZE – ISkUSTVA bOLESNIkA LIJEČENIh U 
SPECIJALNOJ bOLNICI ZA MEDICINSkU REhAbILITACIJU U LIPIkU
V. Vidović, M. Časar Rovazdi, S. Rendulić Slivar, O. Kraml i V. Bašić Kes
U studiji je obuhvaćen 61 oboljeli od multiple skleroze. Svi su bili hospitalizirani u našoj ustanovi od 1. listopada 2013. 
do 15. veljače 2014. Cilj rada je bio istražiti bolne sindrome pridružene osnovnoj bolesti. bolovi su bili prisutni u 90% is-
pitanika. Najveći broj oboljelih imao je bolove u leđima (52%) i mišićno-zglobno-koštane bolove (39%), nakon čega slijede 
bolovi u vratu (31%), bolni tonički spazmi (26%), neuropatski bolovi u ekstremitetima (23%) i bolovi uslijed spasticiteta 
(21%). Drugi tipovi bolova bili su prisutni u manje od 20% oboljelih. Analgetike je uzimalo 67% ispitanika, najčešće ne-
steroidne antireumatike, dok je lijekove protiv neuropatskih bolova uzimao manji broj bolesnika. Visoka učestalost bolnih 
sindroma ukazuje na važnost redovitih postupaka fizikalnih terapija.
ključne riječi: Multipla skleroza; Bol; Analgetici
